Remdesivir: Current Affairs, GK & News - 2020-2021

What is Emergency Use Authorization?

Published: December 3, 2020

Recently, several drug makers are seeking Emergency Use Authorisation (EUA) for the COVID-19 vaccine. Pfizer had applied for the EUA in UK and has been approved by the Medicines and Healthcare Products Regulatory Agency of the country. Also, the Serum Institute of India and Moderna have also applied for the Emergency Use Authorisation of COVID-19 ..

Month: 

Category: 

Topics: 

India contributes 3,000 vials of Remdesivir to Myanmar

Published: October 5, 2020

On October 5, 2020, the Government of India contributed 3,000 vials to Myanmar under the framework of India-Myanmar Foreign Office Consultation. Highlights The 3,000 vials of Remdesivir drug was provided by Army Chief Naravane to the Myanmar State counsellor Aung San Suu Kyi. The vias were provided under Neighbourhood First Policy of India to help ..

Month: 

Category: 

Topics: 

Zydus Cadila launched the cheapest generic version of Remdesivir in India

Published: August 13, 2020

Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug Remdesivir in India to treat the deadly COVID 19 pandemic. The version has been launched after reports of a shortage of the drugs in the hospitals of the country. The price of drugs has been fixed as Rs 2800 per 100 mg vial. ..

Month: 

Category: 

Topics: 

“Dexamethasone” added to COVID-19 treatment protocol

Published: June 29, 2020

The Union Ministry of Health and Family Welfare recently included the use of steroid Dexamethasone in COVID-19 treatment. The ministry has also recommended the use of Remdesivir on patients that are moderately ill. Hydroxychloroquine is to be used during early course of the disease. Highlights The new COVID-19 treatment protocol of the health ministry says ..

Month: 

Category: 

Topics: 

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

Published: June 22, 2020

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals were granted approval by the Drug Controller General of India for the production and marketing ..

Month: 

Category: 

Topics: 

Advertisement